We hypothesize that in low-grade gliomas, GADD45G upregulation may inhibit tumor progression, whereas, in malignant tumors, the suppression of GADD45G expression by tumor cells could contribute to tumor deterioration. Here, GADD45G is linked to central nervous system cancer.